MetaVia Inc. (MTVA) - Pendapatan lan volume dodolan
MetaVia Inc develops cutting-edge treatments for brain pathologies, protecting its assets with unique patents to drive share price growth. The company's sales growth rate demonstrates real revenue dynamics, where 0.00 captures the magnitude of this parameter. The scaling potential is immense: a single successful drug would generate colossal profits. Currently, the business is focused on preclinical trials and the legal securing of intellectual property rights.
Rincian metrik komprehensif lan analitis MetaVia Inc. (MTVA)
- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi pasar:
- rincian nilai buku perusahaan:
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas MetaVia Inc|MTVA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas MetaVia, Inc.|MTVA - Utang perusahaan|Utang marang nilai buku MetaVia Inc.|MTVA - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak MetaVia|Likuiditas cepet metaviatx.com
- indikator bathi lan kelipatan valuasi:
MTVA - Bathi resik|Proyeksi bathi mangsa ngarep MetaVia Inc|MTVA - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep MetaVia, Inc.|MTVA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MetaVia Inc.|MTVA - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) MetaVia|MTVA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan metaviatx.com|MTVA - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep MetaVia Inc
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:MTVA metaviatx.com
This indicator aggregates the daily revenue of MetaVia Inc (MTVA), allowing for a comparison of current cash flow against the company's multi-year business history. Since MetaVia Inc (MTVA) is in the pre-commercial drug development stage, there are no market sales. By analyzing the company's sales figures, an investor finds confirmation of a lack of pricing power prior to regulatory approval. The current stagnation of this metric objectively reflects the specifics of the issuer's biotechnological development cycle.
Perusahaan pesaing
Biogen Idec (BIIB) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan NBIX|Pendapatan lan volume dodolan regencellbioscience.com (RGC)|Axsome Therapeutics, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan ACAD|Xenon Pharmaceuticals Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Viking Therapeutics Corp VKTX|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Volume dodolan perusahaan CPRX|DNLI (Denali Therapeutics Inc.) - Pendapatan lan volume dodolan|Dodolan perusahaan Harmony Biosciences Inc (HRMY)|Pendapatan perusahaan Biohaven Pharmaceutical (BHVN)|Dodolan perusahaan Amylyx Corp AMLX|Trevi Therapeutics - Dodolan perusahaan|Total dodolan perusahaan PRAX (praxismedicines.com)|AVXL: Dodolan perusahaan|CBLL: Pendapatan perusahaan|PRTA: Pendapatan lan volume dodolan|Alector (ALEC) - Pendapatan lan volume dodolan|Pendapatan perusahaan Annexon, Inc.|Volume dodolan perusahaan OMER (Omeros Corp.)|Pendapatan lan volume dodolan NGNE|ACIU - Total pendapatan perusahaan|Voyager Pharma - Dodolan perusahaan|Pendapatan lan volume dodolan Neumora Corp NMRA|SCLX - Pendapatan perusahaan|Pendapatan dodolan perusahaan TVGN (tevogen.com)|alphacognition.com (ACOG) - Pendapatan perusahaan|Total pendapatan perusahaan cogrx.com (CGTX)|Pendapatan perusahaan Inhibikase|Dodolan perusahaan Cassava Pharma (SAVA)|Pendapatan lan volume dodolan ASRT|COYA - Total pendapatan perusahaan|Vistagen - Dodolan perusahaan|Total dodolan perusahaan OVID (Ovid Therapeutics Inc)|Acumen Pharma - Pendapatan lan volume dodolan|CRVO - Pendapatan lan volume dodolan|ATHE (alteritytherapeutics.com) - Dodolan perusahaan|CLNN (Clene) - Pendapatan perusahaan|PEPG (PepGen Inc) - Pendapatan lan volume dodolan|jupiterneurosciences.com (JUNS) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan RLMD|Pendapatan lan volume dodolan Annovis Bio Corporation (ANVS)|Grace Therapeutics - Dodolan perusahaan|Pendapatan dodolan perusahaan AIFF|ANEW Medical, Inc. - Pendapatan lan volume dodolan|Pendapatan reged perusahaan NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Pendapatan perusahaan|Volume dodolan perusahaan NRXS|HSDT (Helius Medical Technologies, Inc.) - Pendapatan lan volume dodolan|Dodolan perusahaan Passage Bio Corp (PASG)|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|Dodolan perusahaan Minerva Neurosciences Inc NERV|Athira - Dodolan perusahaan|Total dodolan perusahaan ADXN (Addex)|ALZN: Dodolan perusahaan|CYCN: Pendapatan perusahaan|PTIX: Pendapatan lan volume dodolan|Pasithea Therapeutics Corp. (KTTA) - Pendapatan lan volume dodolan|Pendapatan perusahaan Cortigent Inc|Volume dodolan perusahaan ATXI (Avenue Therapeutics Inc)|Pendapatan lan volume dodolan BCLI|CARA - Total pendapatan perusahaan|Chromocell Therapeutics Corp. - Dodolan perusahaan|Pendapatan lan volume dodolan Eliem Therapeutics, Inc. ELYM|ITCI - Pendapatan perusahaan|Pendapatan dodolan perusahaan LBPH (Longboard)|Marinus Pharmaceuticals (MRNS) - Pendapatan perusahaan|Total pendapatan perusahaan nkgenbiotech.com (NKGN)|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Dodolan perusahaan Sage Therapeutics Inc. (SAGE)|Pendapatan lan volume dodolan SNPX|TRVN - Total pendapatan perusahaan|Vigil Neuroscience, Inc. - Dodolan perusahaan|Total dodolan perusahaan WENA (Anew Medical Inc.)|Cerevel Therapeutics, Inc. - Pendapatan lan volume dodolan
